A Decade of Misconduct

A senior cardiovascular disease and diabetes researcher at the University of Kentucky has been found guilty of falsifying data over the past 10 years.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Main Building at the University of Kentucky Wikimedia, SeicerFederal investigators have censured a former University of Kentucky (UK) senior biomedical researcher for serial scientific misconduct over a 10-year period, including the falsification of data in grant applications, progress reports, and published papers. The US Office of Research Integrity (ORI) announced the findings last week (November 20) with a notice in the Federal Register.

A joint investigation carried out over the course of 2 years by the ORI and the UK found that Eric Smart, who studied the molecular mechanisms behind cardiovascular diseases and diabetes, had falsified or fabricated a total of 45 figures—mostly images of Western blots, a technique used to identify proteins—in seven grant applications, three progress reports, and 10 published papers, some of which were cited more than 100 times, according to Thomson Scientific’s Web of Knowledge. The notice says that Smart also reported experimental data from knockout mice that did not exist.

“This is surprising and disappointing news to me,” said Philippe Frank of Thomas Jefferson University in Philadelphia. “Dr. Smart's papers were highly cited in the specific caveolae/cardiovascular research field.” William Sessa of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies